Public Health England (PHE) is evaluating the effectiveness of short and long vaccination schedules and will report the findings in due course. PHE has reported vaccine effectiveness against symptomatic disease, hospitalisation and death using two doses in the weekly COVID-19 vaccine surveillance reports, which are available at the following link:<\/p>
https://www.gov.uk/government/publications/covid-19-vaccine-surveillance-report<\/a><\/p> As the majority of individuals in the United Kingdom received their second dose with the extended schedule, these results largely reflect extended schedules. These findings suggest that effectiveness is at least as high as that reported elsewhere where shorter dosing intervals are being used.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-06-09", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-06-09T13:10:21.563Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-05-27", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the effectiveness of the timescale between first and second covid-19 vaccinations.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4638", "label" : {"_value" : "Biography information for Mr Tanmanjeet Singh Dhesi"}
}
, "tablingMemberConstituency" : {"_value" : "Slough"}
, "tablingMemberPrinted" : [{"_value" : "Mr Tanmanjeet Singh Dhesi"}
], "uin" : "8715"}
, {"_about" : "http://data.parliament.uk/resources/1328925", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1328925/answer", "answerText" : {"_value" : " Public Health England (PHE) has published early estimates of vaccine effectiveness against symptomatic disease with the B.1.617.2 variant which are available at the following link:<\/p> https://www.medrxiv.org/content/10.1101/2021.05.22.21257658v1<\/a><\/p> The number of hospitalised cases and deaths from the B.1.617.2 variant of COVID-19 are currently too small to estimate vaccine effectiveness against these outcomes. PHE will continue to monitor the impact of the COVID-19 vaccines on variant B.1.617.2.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-06-07", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-06-07T15:51:17.763Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-05-27", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the efficacy of vaccination in preventing (a) transmission, (b) hospitalisation and (c) death arising from the B.1.617.2 variant of covid-19.", "registeredInterest" : {"_value" : "true", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1520", "label" : {"_value" : "Biography information for Mr Mark Harper"}
}
, "tablingMemberConstituency" : {"_value" : "Forest of Dean"}
, "tablingMemberPrinted" : [{"_value" : "Mr Mark Harper"}
], "uin" : "8562"}
, {"_about" : "http://data.parliament.uk/resources/1328939", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1328939/answer", "answerText" : {"_value" : " As of 27 May 2021, the number of people in Bromsgrove Lower Tier Local Authority (LTLA) who have received a first dose and those who have received first and second doses are 65,668 and 46,519 respectively.<\/p> The estimated percentage of those aged 16 years old and over who have had at least one dose of the COVID-19 vaccine in Bromsgrove LTLA is 77.1%, based on population figures of 85,144. However, it should be noted that general practice boundaries are not necessarily coterminous with LTLA boundaries and therefore people outside of the Bromsgrove LTLA area may have been vaccinated in a Bromsgrove GP practice and vice versa. 16 years old and older, rather than 18 years old and over, has been given as the lowest relevant age cohort for population estimates across English geographies available on the National Immunisation Managements Service (NIMS) is 16-29.<\/p> Further information can be found at the following link: www.england.nhs.uk/statistics/statistical-work-areas/covid-19-vaccinations/<\/a><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-06-10", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "8582"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-06-10T15:57:41.747Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-05-27", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, how many people have received (a) one dose and (b) two doses of the covid-19 vaccination in Bromsgrove District according to the latest available data.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/3945", "label" : {"_value" : "Biography information for Sir Sajid Javid"}
}
, "tablingMemberConstituency" : {"_value" : "Bromsgrove"}
, "tablingMemberPrinted" : [{"_value" : "Sajid Javid"}
], "uin" : "8581"}
, {"_about" : "http://data.parliament.uk/resources/1328940", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1328940/answer", "answerText" : {"_value" : " As of 27 May 2021, the number of people in Bromsgrove Lower Tier Local Authority (LTLA) who have received a first dose and those who have received first and second doses are 65,668 and 46,519 respectively.<\/p> The estimated percentage of those aged 16 years old and over who have had at least one dose of the COVID-19 vaccine in Bromsgrove LTLA is 77.1%, based on population figures of 85,144. However, it should be noted that general practice boundaries are not necessarily coterminous with LTLA boundaries and therefore people outside of the Bromsgrove LTLA area may have been vaccinated in a Bromsgrove GP practice and vice versa. 16 years old and older, rather than 18 years old and over, has been given as the lowest relevant age cohort for population estimates across English geographies available on the National Immunisation Managements Service (NIMS) is 16-29.<\/p> Further information can be found at the following link: www.england.nhs.uk/statistics/statistical-work-areas/covid-19-vaccinations/<\/a><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-06-10", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "8581"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-06-10T15:57:41.683Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-05-27", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what percentage of adults in Bromsgrove District have received a covid-19 vaccination according to the latest available data.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/3945", "label" : {"_value" : "Biography information for Sir Sajid Javid"}
}
, "tablingMemberConstituency" : {"_value" : "Bromsgrove"}
, "tablingMemberPrinted" : [{"_value" : "Sajid Javid"}
], "uin" : "8582"}
, {"_about" : "http://data.parliament.uk/resources/1328985", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1328985/answer", "answerText" : {"_value" : " Children under 16 years of age, even if they are clinically extremely vulnerable (CEV), are at low risk of serious morbidity and mortality from COVID-19. There is also a lack of safety and efficacy data for COVID-19 vaccines in children. Most children under the age of 16, including those who are CEV, are therefore not recommended for routine vaccination.<\/p> Given the very high risk of exposure to infection and outbreaks in residential settings, vaccination may be appropriate for those with severe neuro-disabilities who require frequent care in these settings. This option should be discussed between parents or guardians and the child\u2019s clinician.<\/p> As of 1 April, due to low prevalence, shielding advice has been paused for all clinically extremely vulnerable people, including children and young people. All CEV pupils should attend their school unless they are one of the very small number of pupils under paediatric or other specialist care and have been advised by their GP or clinician not to attend. Pupils who live with someone who is CEV should continue to attend school as normal.<\/p> More information on children and COVID-19 vaccination can be found at the following link: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/984310/Greenbook_chapter_14a_7May2021.pdf<\/a><\/p>